Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers

The Nature and Significance of Osteopontin

1989 • 561 citations

Calcitonin alters behaviour of isolated osteoclasts

1982 • 509 citations

Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy.

1990 • 281 citations

Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

1995 • 234 citations

Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line.

1992 • 209 citations

Cloning and characterization of an abundant subtype of the human calcitonin receptor.

1994 • 151 citations

Physiology and Pharmacology of Bone

1993 • 150 citations

The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.

1996 • 147 citations

Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.

1994 • 146 citations

Expression of bone sialoprotein, a bone matrix protein, in human breast cancer.

1994 • 143 citations

In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo

1994 • 123 citations

Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.

1980 • 115 citations

Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript.

1995 • 99 citations

Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours

1995 • 77 citations

Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells.

1983 • 74 citations

Somatostatin receptors and disease: Role of receptor subtypes

1996 • 70 citations

Pathophysiology of Skeletal Complications of Cancer

1993 • 33 citations